|
|
 |
 |
| |
 Printable version |
Breast implants and health alert PIP: experience of the regional cancer center of Lille |
Bulletin du Cancer. Volume 99, Number 2, 147-53, Février 2012, Article original
|
 Résumé
Article gratuit
|
Author(s) : Marie-Astrid Carillon, Sylvia Giard, Virginie Emmanuelli, Jean-Louis Houpeau, Luc Ceugnart, Marie-Pierre Chauvet |
Summary :
Introduction. On March 30, 2010, Afssaps issued a health alert concerning breast implants brand PIP, after identifying a rupture rate higher than for other manufacturers. This alert asking the recall of all concerned patients with, according to the clinical examination, ultrasound and the desire of the patient, the possibility of explantation. We focus on PIP implanted in Oscar-Lambret center in Lille.
Materials and patients. A retrospective study on all patients carrying breast prosthesis PIP implanted in the Oscar-Lambret center. We are interested in the rate of patients who chose clinical and ultrasound monotoring, explantation rates, and prosthetic rupture.
Results. Thirty-three PIP (in 31 patients) have been implanted in the center between May 2, 2006 and March 9, 2010. The mean age of implants was 15.35 months. We realized eight explants, and found three intracapsular rupture. Two of three rupture were symptomatic.
Conclusion. The majority of patients chose surveillance. Our short series does not give precise information about their risk of prosthetic failure, a national register should be established. The literature illustrates the low sensitivity of ultrasonography in the diagnosis of intracapsular rupture and the superiority of MRI. In the context of a health alert, could we propose a monitoring tool implant breast MRI in order to minimize the rate of patients carrying a ruptured implant (false negative). |
Keywords : breast implant PIP, intracapsular rupture, extracapsular rupture, explantation |
|
